Calcitonin-Salmon (Calcitonin,Salmon,Synthetic) Patent Expiration, LOE Window & CMS Spending

Calcitonin-Salmon (Calcitonin,Salmon,Synthetic) by Apotex: Off-Patent Genericized (AB Competition), 2 AB generics, $15.2M 2024 CMS Part D & Medicaid spend, and $2,661 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorApotex
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors2
2024 CMS Total Public Spend$15.2M
2024 Medicare Part D Spend$14.1M
2024 Medicaid Spend$1.1M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($2,661 intro WAC)